Average obligated amount per year since period start.
Portion of total contract value already obligated.
Share of total value represented by subawards.
TAS::75 0844::TAS SINGLE DOSE, DOSE-RANGING AND 28 DAYS REPEAT-DOSE SAFETY AND TOLERABILITY, PHARMACOKINETICS, AND PHARMACODYNAMICS STUDY OF DIMETHANDROLONE UNDECANOATE DMAU IN HEALTHY MEN
Task order obligations
Estimated months remaining until end of performance.
Period of performance
100% of period elapsed
Awardee
LILUNDQUIST INSTITUTE FOR BIOMEDICAL INNOVATION AT HARBOR-UCLA MEDICAL CENTER
UEI: LTJVF4QSFCP9
Awarding Agency
NINATIONAL INSTITUTES OF HEALTH
Code: 7529
Funding Agency
NINATIONAL INSTITUTES OF HEALTH
Code: 7529
Loading contract activity data...
Modification ID | Description | Action Date | Obligated Amount | Action Type |
|---|---|---|---|---|
Subaward # | Subawardee | Description | Amount | Action Date |
|---|---|---|---|---|